Link Biologics
PrivateLast Round
Strategic
Sep 12, 2023
Company Overview
Link Biologics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in June 2022.
Link Biologics is a biopharmaceutical company that develops protein biologics based on TSG-6 for people living with inflammatory and degenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Biologics Comparables
Compare Link Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OKYO Pharma | 75% | |
| Selagine, Inc. | 73% | |
| Stuart Therapeutics, Inc. | 71% |
For institutional investors. Book with your work email.
Link Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 12, 2023 | ||||
| Accelerator | Jun 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Link Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| Théa Open Innovation | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 169% MoM, from 75 to 202.
- Dec 7, 2025
Monthly visitors grew 137% MoM, from 41 to 97.
For institutional investors. Book with your work email.
Link Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Link Biologics's valuation, stock price, and market status.
Is Link Biologics a public or private company?
Link Biologics is a private company.
What is the current stock price of Link Biologics?
Link Biologics is a private company, so its shares have no public market price. Caplight tracks Link Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Link Biologics worth (valuation)?
Valuation information for Link Biologics is not publicly available.
Can I buy Link Biologics stock?
Link Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Link Biologics's last funding round?
Link Biologics's most recent funding round was Strategic on September 12, 2023.
Who are the main investors in Link Biologics?
Key investors in Link Biologics include Théa Open Innovation.
Will Link Biologics IPO soon?
No public IPO plans have been announced for Link Biologics.
How can I track Link Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Link Biologics's shares on secondary markets.